213 related articles for article (PubMed ID: 19220839)
1. CpG-oligodeoxynucleotides stimulate immunoglobulin A secretion in intestinal mucosal B cells.
Blaas SH; Stieber-Gunckel M; Falk W; Obermeier F; Rogler G
Clin Exp Immunol; 2009 Mar; 155(3):534-40. PubMed ID: 19220839
[TBL] [Abstract][Full Text] [Related]
2. Expression of Toll-like receptor 9 and response to bacterial CpG oligodeoxynucleotides in human intestinal epithelium.
Pedersen G; Andresen L; Matthiessen MW; Rask-Madsen J; Brynskov J
Clin Exp Immunol; 2005 Aug; 141(2):298-306. PubMed ID: 15996194
[TBL] [Abstract][Full Text] [Related]
3. Lipopolysaccharides-Induced Suppression of Innate-Like B Cell Apoptosis Is Enhanced by CpG Oligodeoxynucleotide and Requires Toll-Like Receptors 2 and 4.
Yu X; Wang Y; Lin J; Hu Y; Kawai T; Taubman MA; Han X
PLoS One; 2016; 11(11):e0165862. PubMed ID: 27812176
[TBL] [Abstract][Full Text] [Related]
4. Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides.
Hornung V; Rothenfusser S; Britsch S; Krug A; Jahrsdörfer B; Giese T; Endres S; Hartmann G
J Immunol; 2002 May; 168(9):4531-7. PubMed ID: 11970999
[TBL] [Abstract][Full Text] [Related]
5. Toll-like receptor 9 activation induces expression of membrane-bound B-cell activating factor (BAFF) on human B cells and leads to increased proliferation in response to both soluble and membrane-bound BAFF.
Abu-Rish EY; Amrani Y; Browning MJ
Rheumatology (Oxford); 2013 Jul; 52(7):1190-201. PubMed ID: 23436580
[TBL] [Abstract][Full Text] [Related]
6. CpG oligodeoxynucleotides induce expression of proinflammatory cytokines and chemokines in astrocytes: the role of c-Jun N-terminal kinase in CpG ODN-mediated NF-kappaB activation.
Lee S; Hong J; Choi SY; Oh SB; Park K; Kim JS; Karin M; Lee SJ
J Neuroimmunol; 2004 Aug; 153(1-2):50-63. PubMed ID: 15265663
[TBL] [Abstract][Full Text] [Related]
7. Toll-like receptor signaling in small intestinal epithelium promotes B-cell recruitment and IgA production in lamina propria.
Shang L; Fukata M; Thirunarayanan N; Martin AP; Arnaboldi P; Maussang D; Berin C; Unkeless JC; Mayer L; Abreu MT; Lira SA
Gastroenterology; 2008 Aug; 135(2):529-38. PubMed ID: 18522803
[TBL] [Abstract][Full Text] [Related]
8. Synthetic CpG oligodeoxynucleotides augment BAFF- and APRIL-mediated immunoglobulin secretion.
Katsenelson N; Kanswal S; Puig M; Mostowski H; Verthelyi D; Akkoyunlu M
Eur J Immunol; 2007 Jul; 37(7):1785-95. PubMed ID: 17557373
[TBL] [Abstract][Full Text] [Related]
9. Bacterial peptidoglycans but not CpG oligodeoxynucleotides activate synovial fibroblasts by toll-like receptor signaling.
Kyburz D; Rethage J; Seibl R; Lauener R; Gay RE; Carson DA; Gay S
Arthritis Rheum; 2003 Mar; 48(3):642-50. PubMed ID: 12632416
[TBL] [Abstract][Full Text] [Related]
10. Impaired toll-like receptor 9 expression in alveolar macrophages with no sensitivity to CpG DNA.
Suzuki K; Suda T; Naito T; Ide K; Chida K; Nakamura H
Am J Respir Crit Care Med; 2005 Apr; 171(7):707-13. PubMed ID: 15640365
[TBL] [Abstract][Full Text] [Related]
11. T cell-dependent protective effects of CpG motifs of bacterial DNA in experimental colitis are mediated by CD11c+ dendritic cells.
Hofmann C; Dunger N; Grunwald N; Hämmerling GJ; Hoffmann P; Schölmerich J; Falk W; Obermeier F
Gut; 2010 Oct; 59(10):1347-54. PubMed ID: 20732920
[TBL] [Abstract][Full Text] [Related]
12. Phosphorothioate-modified CpG oligodeoxynucleotides mimic autoantigens and reveal a potential role for Toll-like receptor 9 in receptor revision.
Doster A; Ziegler S; Foermer S; Rieker RJ; Heeg K; Bekeredjian-Ding I
Immunology; 2013 Jun; 139(2):166-78. PubMed ID: 23289794
[TBL] [Abstract][Full Text] [Related]
13. Heterozygous carriage of a dysfunctional Toll-like receptor 9 allele affects CpG oligonucleotide responses in B cells.
Knezević J; Pavlinić D; Rose WA; Leifer CA; Bendelja K; Gabrilovac J; Parcina M; Lauc G; Kubarenko AV; Petricevic B; Vrbanec D; Bulat-Kardum L; Bekeredjian-Ding I; Pavelić J; Dembić Z; Weber AN
J Biol Chem; 2012 Jul; 287(29):24544-53. PubMed ID: 22613717
[TBL] [Abstract][Full Text] [Related]
14. Increased immunoglobulin A in alcoholic liver cirrhosis: exploring the response of B cells to Toll-like receptor 9 activation.
Massonnet B; Delwail A; Ayrault JM; Chagneau-Derrode C; Lecron JC; Silvain C
Clin Exp Immunol; 2009 Oct; 158(1):115-24. PubMed ID: 19737238
[TBL] [Abstract][Full Text] [Related]
15. Cross-talk between toll-like receptors 5 and 9 on activation of human immune responses.
Merlo A; Calcaterra C; Mènard S; Balsari A
J Leukoc Biol; 2007 Sep; 82(3):509-18. PubMed ID: 17586660
[TBL] [Abstract][Full Text] [Related]
16. A distinct Toll-like receptor repertoire in human tonsillar B cells, directly activated by PamCSK, R-837 and CpG-2006 stimulation.
Månsson A; Adner M; Höckerfelt U; Cardell LO
Immunology; 2006 Aug; 118(4):539-48. PubMed ID: 16780564
[TBL] [Abstract][Full Text] [Related]
17. [Modulation of TLR9 on anti-tumor immune responses of peripheral blood mononuclear cells from patients with non-small-cell lung cancer].
Ren T; Cai YY; Liang YJ; Jin ML; Guo ZL; Tao MF; He X
Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(17):1168-72. PubMed ID: 18844109
[TBL] [Abstract][Full Text] [Related]
18. Increased frequency of immunoglobulin (Ig)A-secreting cells following Toll-like receptor (TLR)-9 engagement in patients with Kawasaki disease.
Giordani L; Quaranta MG; Marchesi A; Straface E; Pietraforte D; Villani A; Malorni W; Del Principe D; Viora M
Clin Exp Immunol; 2011 Mar; 163(3):346-53. PubMed ID: 21175593
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-21 is increased in active systemic lupus erythematosus patients and contributes to the generation of plasma B cells.
Nakou M; Papadimitraki ED; Fanouriakis A; Bertsias GK; Choulaki C; Goulidaki N; Sidiropoulos P; Boumpas DT
Clin Exp Rheumatol; 2013; 31(2):172-9. PubMed ID: 23137515
[TBL] [Abstract][Full Text] [Related]
20. IFN-alpha amplifies human naive B cell TLR-9-mediated activation and Ig production.
Giordani L; Sanchez M; Libri I; Quaranta MG; Mattioli B; Viora M
J Leukoc Biol; 2009 Aug; 86(2):261-71. PubMed ID: 19401392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
